Professor Mutay Aydın Aslan, MD, PhD, graduated from Çukurova University Faculty of Medicine and completed her medical residency in Medical Biochemistry at Akdeniz University Faculty of Medicine, Türkiye. She earned her PhD in Biochemistry and Molecular Genetics from the University of Alabama at Birmingham (USA) and subsequently completed postdoctoral research there. Prof. Aslan is currently a Professor in the Department of Medical Biochemistry at Akdeniz University Faculty of Medicine and serves as Director of the Central Laboratory at Akdeniz University Hospital. Her research focuses on lipid biochemistry, particularly lipoproteins, fatty acids, sphingolipids, and lipid-mediated signaling pathways in metabolic diseases and cancer. She has served as a member of EU-COST actions, including the Management Committee of COST Action BM1203, and has been an independent expert evaluator for the European Commission in the review of international research proposals. She also served as a member of the FEBS Advanced Courses Committee (2021–2024). Prof. Aslan has authored more than 145 peer-reviewed publications and holds international patents. According to Google Scholar (2025), her work has received over 6,263 citations with an h-index of 41. She also serves on the editorial boards of Frontiers in Cellular Biochemistry and Frontiers in Oxidant Physiology.